Merril Pharma Pvt. Ltd. has rapidly emerged as the fastest growing pharmaceutical company globally, boasting annual revenues surpassing 10 million USD. Our success is underpinned by the support of two state-of-the-art WHO GMP certified manufacturing units, aligning with the highest standards of pharmaceutical production. As an elite member of the Indian Drug Manufacturing Association (IDMA), we pride ourselves on being a GMP certified pharma company, ensuring the quality and efficacy of our pharmaceutical formulations.
Our cutting-edge manufacturing facilities incorporate advanced technology, enabling us to produce a diverse range of high-quality, affordable medicines. Trusted by healthcare professionals and patients nationwide, our products span across Pan India and are exported to the CIS Region, African Countries, Middle East, and Asia Pacific Region, positioning us as a top pharma exporter. With a broad portfolio encompassing over 500 high-quality molecules in various dosage forms, including tablets, capsules, ointments, creams, and liquids, we cater to a wide spectrum of chronic and acute therapies.
Merril Pharma specializes in contract manufacturing of pharma products, establishing itself as a top pharma franchise company with a reputation for excellence. Our WHO GMP certified pharma formulation company prioritizes innovation and quality assurance, reflecting in our neuro-psychiatry, cardiology, gastroenterology, anti-infective, diabetology, dermatology, urology, nephrology, respiratory, obs & gyn, NSAIDs, and OTC products. As a leading healthcare and pharmaceutical company, we are committed to delivering top-notch pharmaceutical products that enhance the well-being of individuals worldwide.
Additionally, we offer a comprehensive product list of healthcare pharmaceuticals, reflecting our commitment to meeting the diverse needs of patients and healthcare professionals. Our focus on the production of pharmaceutical products underscores our dedication to innovation and quality in every aspect of our operations.
